Martin Gerstel
 |
This article relies largely or entirely upon a single source. (June 2015) |
Martin Gerstel was born on June 26, 1941. He is a businessman who was the CEO and co-chairman of Alza Corp. He is the chairman of Compugen (Israeli company), Evogene, Keddem Bioscience, Mada Ltd., the co-founder and co-chairman of Itamar Medical, and serves as a director of Yissum Research Development Company of Hebrew University Ltd., Yeda Ltd. and the Foundation for the U.S. National Medals of Science and Technology. He is a member of the Board of Governors and the Executive Committee of the Weizmann Institute of Science and the Board of Governors of The Hebrew University of Jerusalem, and is an advisor to the Burrill Life Science Funds and the board of the Israel-U.S. Binational Industrial Research and Development Foundation (“BIRD”).[1] Gerstel holds a B.S. from Yale University and an MBA from Stanford University.
Gerstel is married to Shoshna Gerstel (Weksler) and is the father of Gil Gerstel.
References[edit]
- ^ "Compugen Ltd (CGEN) – 6-K – 7/2/2003". EDGAR Online. 2 June 2003. Retrieved 15 December 2011.
External links[edit]
- "Martin Gerstel's back in business, this time in Israel" – Israel21c
- Martin S. Gerstel Profile – Forbes.com
- Evogene official site
- Itamar Medical official site
- Yissum official site
- Yeda official site
